Recombinant Human CD99/MIC2 Protein
Beta LifeScience
SKU/CAT #: BLK-02427P-100UG
Human CD99 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human CD99/MIC2 Protein
Beta LifeScience
SKU/CAT #: BLK-02427P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human CD99/MIC2 Protein is expressed from HEK293 with His tag at the N-Terminus.It contains Asp23-Asp122. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | AAH02584 |
Target Symbol | CD99/MIC2 |
Synonyms | 12E7; E2 antigen; MIC2; MIC2X; MIC2Y; CD99; HBA71; MSK5X; 12E7; 1110061M03Rik; 2410026K10Rik; D4; pilr-1; Pilr-l; CD99 molecule |
Species | Human |
Expression System | HEK293 |
Tag | N-His |
Expression Range | Asp23-Asp122 |
Mol. Weight | The protein has a predicted MW of 11.2 kDa. Due to glycosylation, the protein migrates to 20-25 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | CD99 is a cell surface protein with unique features and only partly defined mechanisms of action. This molecule is involved in crucial biological processes, including cell adhesion, migration, death, differentiation and diapedesis, and it influences processes associated with inflammation, immune responses and cancer. CD99 is frequently overexpressed in many types of tumors, particularly pediatric tumors including Ewing sarcoma and specific subtypes of leukemia. |